［1］Li Y,O′Connell P,Breidenbach HH,et al.Genomic organization of the neurofibromatosis 1 gene(NFl)［J］.Genomics，1995，25（1）:9-18.
［2］Xu GF,Lin B,Tanaka K, et al.The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S.cerevisiae［J］.Cell，
1990，63（4）:835-841.
［3］Rasmussen SA,Friedman JM. NF1 gene and neurofibromatosis 1［J］.Am J Epidemiol,2000,151(1):33-40.
［4］Huson SM,Compston DA, Clark P, et al. A genetic study of von Recklinghausen neurofibromatosis in southeast Wales.I.Prevalence,fitness,mutation rate,and effect of parental
transmission on severity［J］.J Med Genet,1989，26(1):704-711.
［5］Kang JH,Kim OS,Kim JH,et al.A novel mutation of exon 7 in growth hormone receptor mRNA in a patient with growth hormone insensitivity syndrome and neurofbromatosis type I［J］.Int J Mol Med,2012,30(3):713-717.
［6］Ars E,Serra E,Garcia J,et al.Mutations affecting mRNA splicing are the most most common molecular defects in patients with neurofibromatosis type 1［J］.Hum Mol
Genet,2000,9(2):237-247.
［7］Ars E,Kruyer H,Gaona A,et al.A clinical variant of neurofibromatosis type 1:familial spinal neurofibromatosis with a frameshift mutationin the NF-1 gene［J］.Am J Hum
Genet,1998,62(4):834-841.
［8］Martins CL,Monteiro JP,Farias A,et al.Managing children with neurofibromatosis type 1:what should we look for?［J］.Acta Med Port,2007,20(5):393-400.
［9］杨志寅.现代医学科学发展中的缺憾与思考［J/CD］.中华诊断学电子杂志，2013，1（1）：1-7.
［10］潘祥林，王鸿利.诊断学的任务与发展方向［J/CD］.中华诊断学电子杂志，2013，1（1）：8-9.
